Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.
CAT No: R1351
CAS No:25422-31-5
Synonyms/Alias:Fibrinopeptide A, human;25422-31-5;Fibrinopeptide A human;Human fibrinopeptide A;ADSGEGDFXAEGGGVR;DA-53189;Fibrinopeptide A human, >=96% (HPLC);
Fibrinopeptide A, human, is a synthetic peptide corresponding to the N-terminal segment released from the alpha chain of human fibrinogen during the enzymatic cleavage by thrombin. As a well-characterized peptide fragment, it plays a pivotal role in the coagulation cascade, specifically marking the transition from soluble fibrinogen to insoluble fibrin. Its defined sequence and functional significance make it a valuable tool for researchers investigating hemostasis, thrombosis, and related biochemical processes. The ability to obtain this peptide in pure, isolated form allows for precise experimental manipulation and quantification in a variety of in vitro systems, facilitating advances in both basic and applied biomedical research.
Coagulation research: As a direct substrate and product of thrombin activity, Fibrinopeptide A is widely utilized in studies dissecting the molecular mechanisms of blood coagulation. Researchers employ it to monitor thrombin generation, assess fibrinogen cleavage kinetics, and investigate the regulation of clot formation pathways. Its use enables detailed analysis of the enzymatic steps leading to fibrin polymerization, providing insight into the dynamics of hemostatic processes under both physiological and pathological conditions.
Analytical assay development: The peptide serves as a standard or calibrator in quantitative analytical assays, such as enzyme-linked immunosorbent assays (ELISAs) and mass spectrometry-based methods. Its well-defined sequence and immunogenic properties allow for the development and validation of sensitive detection systems for fibrinopeptide A in biological fluids. These assays are instrumental in measuring thrombin activity, monitoring coagulation status, and supporting research into disorders of hemostasis.
Peptide mapping and mass spectrometry: Fibrinopeptide A is frequently used as an internal standard or reference peptide in mass spectrometry workflows. Its known mass and fragmentation pattern make it ideal for instrument calibration, method validation, and quality control in proteomic analyses. The peptide's application in peptide mapping protocols enhances the accuracy of protein identification and quantification, particularly in studies involving fibrinogen and its derivatives.
Receptor binding and signaling studies: The interaction of fibrinopeptide A with specific cellular receptors, such as those on platelets or endothelial cells, is of significant interest in elucidating the downstream signaling pathways activated during coagulation. In vitro experiments utilizing this peptide help characterize receptor specificity, binding affinities, and the subsequent cellular responses, thereby contributing to a deeper understanding of the molecular events associated with vascular biology and inflammation.
Peptide synthesis and modification research: The defined structure of Fibrinopeptide A makes it an excellent model for exploring synthetic strategies and post-synthetic modifications in peptide chemistry. Researchers use it to evaluate new coupling reagents, optimize purification protocols, and investigate the effects of sequence alterations or labeling on peptide stability and function. Such studies are essential for improving methodologies in peptide synthesis and for the development of novel peptide-based research tools.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.